Biodegradable Polymer DES (Ultimaster) vs. Magnesium Bioresorbable Scaffold (BRS Magmaris) in Diabetic Population with NSTE-ACS: A One-Year Clinical Outcome of Two Sirolimus-Eluting Stents

CONCLUSION: Both, Ultimaster and Magmaris revealed relative safety and efficiency at a one-year follow-up in the diabetic population in ACS settings. The observed rates of TLF were low, which combined with a lack of in-stent thrombosis suggests that both investigated devices might be an interesting therapeutic option for diabetics with ACS. Nevertheless, further large randomized clinical trials are needed to confirm fully our results.PMID:34859105 | PMC:PMC8632392 | DOI:10.1155/2021/8636050

Source: Atherosclerosis - December 3, 2021 Category: Cardiology Authors: Piotr Rola Adrian W łodarczak Mateusz Barycki Marek Szudrowicz Magdalena Łanocha Jan Jakub Kulczycki Karol Turkiewicz Katarzyna Wo źnica Maciej Lesiak Adrian Doroszko Source Type: research